Evoked gamma band synchronization and the liability for schizophrenia

Schizophrenia Research

Volumn 70, Issue 2-3, 2004, Pages 293-302

  Hong, L Elliot ^a   Summerfelt, Ann ^a   McMahon, Robert ^a   Adami, Helene ^a   Francis, Grace ^a   Elliott, Amie ^a   Buchanan, Robert W ^a   Thaker, Gunvant K ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

40 Hz; EEG; Evoked potential; Gamma; Schizophrenia

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; BRAIN; BRAIN CORTEX; BRAIN FUNCTION; CELL SYNCHRONIZATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EVOKED AUDITORY RESPONSE; FEMALE; GAMMA NERVE FIBER; GENETIC PREDISPOSITION; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SYMPTOM;

ADULT; ANTIPSYCHOTIC AGENTS; BRIEF PSYCHIATRIC RATING SCALE; CORTICAL SYNCHRONIZATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; FEMALE; HUMANS; MALE; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 4344645375     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2003.12.011     Document Type: Conference Paper

References (42)

1. Ahveninen J., Kahkonen S., Tiitinen H., Pekkonen E., Huttunen J., Kaakkola S., Ilmoniemi R.J., Jaaskelainen I.P. Suppression of transient 40-Hz auditory response by haloperidol suggests modulation of human selective attention by dopamine D2 receptors. Neurosci. Lett. 292:2000;29-32
2. Aickin M., Gensler H. Adjusting for multiple testing when reporting research results: the Bonferroni vs. Holm methods. Am. J. Public Health. 86:1996;726-728
3. Arvanov V.L., Liang X., Schwartz J., Grossman S., Wang R.Y. Clozapine and haloperidol modulate N-methyl-D-aspartate- and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro. J. Pharmacol. Exp. Ther. 283:1997;226-234
4. Avila M.T., Weiler M., Lahti A.C., Tamminga C.A., Thaker G.K. Effects of ketamine on leading saccades during smooth pursuit eye movements implicate cerebellar dysfunction in schizophrenia. Am. J. Psychiatry. 159:2002;1490-1496
5. Carpenter W.T. Jr., Gold J.M., Lahti A.C., Queern C.A., Conley R.R., Bartko J.J., Kovnick J., Appelbaum P.S. Decisional capacity for informed consent in schizophrenia research. Arch. Gen. Psychiatry. 57:2000;533-538
6. Clementz B.A., Blumenfeld L.D., Cobb S. The gamma band response may account for poor P50 suppression in schizophrenia. NeuroReport. 8:1997;3889-3893
7. Clementz B.A., Geyer M.A., Braff D.L. Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am. J. Psychiatry. 155:1998;1691-1694
8. Dean B., Hussain T., Scarr E., Pavey G., Copolov D.L. Extended treatment with typical and atypical antipsychotic drugs differential effects on the densities of dopamine D2-like and GABAA receptors in rat striatum. Life Sci. 69:2001;1257-1268
9. Faraone S.V., Seidman L.J., Kremen W.S., Toomey R., Pepple J.R., Tsuang M.T. Neuropsychologic functioning among the nonpsychotic relatives of schizophrenic patients: the effect of genetic loading. Biol. Psychiatry. 48:2000;120-126
10. Farnbach-Pralong D., Bradbury R., Copolov D., Dean B. Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptors. Eur. J. Pharmacol. 349:1998;R7-R8
11. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders. 1997;American Psychiatric Publishing Inc., Washington, DC
12. Galambos R., Makeig S., Talmachoff P.J. A 40-Hz auditory potential recorded from the human scalp. Proc. Natl. Acad. Sci. U. S. A. 78:1981;2643-2647
13. Gruber T., Keil A., Muller M.M. Modulation of induced gamma band responses and phase synchrony in a paired associate learning task in the human EEG. Neurosci. Lett. 316:2001;29-32
14. Haig A.R., Gordon E., De P.V., Meares R.A., Bahramali H., Harris A. Gamma activity in schizophrenia: evidence of impaired network binding? Clin. Neurophysiol. 111:2000;1461-1468
15. Hedlund J.L., Vieweg B.W. The Brief Psychiatric Rating Scale (BPRS): a comprehensive review. J. Oper. Psych. 11:1980;48-64
16. Jin Y., Potkin S.G., Sandman C.A., Bunney W.E. Jr. Topographic analysis of EEG photic driving in patients with schizophrenia following clozapine treatment. Clin. Electroencephalogr. 29:1998;73-78
17. Joliot M., Ribary U., Llinas R. Human oscillatory brain activity near 40 Hz coexists with cognitive temporal binding. Proc. Natl. Acad. Sci. U. S. A. 91:1994;11748-11751
18. Kendler K.S., McGuire M., Gruenberg A.M., O'Hare A., Spellman M., Walsh D. The Roscommon family study: III. Schizophrenia-related personality disorders in relatives. Arch. Gen. Psychiatry. 50:1993;781-788
19. Kissler J., Muller M.M., Fehr T., Rockstroh B., Elbert T. MEG gamma band activity in schizophrenia patients and healthy subjects in a mental arithmetic task and at rest. Clin. Neurophysiol. 111:2000;2079-2087
20. Knott V., Labelle A., Jones B., Mahoney C. Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment. Schizophr. Res. 50:2001;41-53
21. Krabbendam L., Marcelis M., Delespaul P., Jolles J., van Os J. Single or multiple familial cognitive risk factors in schizophrenia? Am. J. Med. Genet. 105:2001;183-188
22. Kubota T., Jibiki I., Enokido F., Nakagawa H., Watanabe K. Effects of MK-801 on clozapine-induced potentiation of excitatory synaptic responses in the perforant path-dentate gyrus pathway in chronically prepared rabbits. Eur. J. Pharmacol. 395:2000;37-42
23. Kwon J.S., O'Donnell B.F., Wallenstein G.V., Greene R.W., Hirayasu Y., Nestor P.G., Hasselmo M.E., Potts G.F., Shenton M.E., McCarley R.W. Gamma frequency-range abnormalities to auditory stimulation in schizophrenia. Arch. Gen. Psychiatry. 56:1999;1001-1005
24. Lahti A.C., Weiler M.A., Tamara Michaelidis B.A., Parwani A., Tamminga C.A. Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology. 25:2001;455-467
25. Lee K.H., Williams L.M., Haig A., Goldberg E., Gordon E. An integration of 40 Hz Gamma and phasic arousal: novelty and routinization processing in schizophrenia. Clin. Neurophysiol. 112:2001;1499-1507
26. Lewis D.A. GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia. Brain Res. Brain Res. Rev. 31:2000;270-276
27. Light G.A., Geyer M.A., Clementz B.A., Cadenhead K.S., Braff D.L. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. Am. J. Psychiatry. 157:2000;767-771
28. Palva S., Palva J.M., Shtyrov Y., Kujala T., Ilmoniemi R.J., Kaila K., Naatanen R. Distinct gamma-band evoked responses to speech and non-speech sounds in humans. J. Neurosci. 22:2002;RC211
29. Pfohl B., Blum N., Zimmerman M. Structured Interview for DSM-IV Personality. 1997;American Psychiatric Publishing Inc., Washington, DC
30. Singer W., Gray C.M. Visual feature integration and the temporal correlation hypothesis. Annu. Rev. Neurosci. 18:1995;555-586
31. Small J.G., Milstein V., Small I.F., Miller M.J., Kellams J.J., Corsaro C.J. Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia. Clin. Electroencephalogr. 18:1987;124-135
32. Squires R.F., Saederup E. Additivities of compounds that increase the numbers of high affinity [3H]muscimol binding sites by different amounts define more than 9 GABA(A) receptor complexes in rat forebrain: implications for schizophrenia and clozapine research. Neurochem. Res. 25:2000;1587-1601
33. Tallon-Baudry C., Bertrand O., Delpuech C., Permier J. Oscillatory gamma-band (30-70 Hz) activity induced by a visual search task in humans. J. Neurosci. 17:1997;722-734
34. Tamminga C.A. Schizophrenia and glutamatergic transmission. Crit. Rev. Neurobiol. 12:1998;21-36
35. Thaker G.K. Defining the schizophrenia phenotype. Curr. Psychiatry Rep. 2:2000;398-403
36. Thaker G.K., Ross D.E., Cassady S.L., Adami H.M., LaPorte D., Medoff D.R., Lahti A. Smooth pursuit eye movements to extraretinal motion signals: deficits in relatives of patients with schizophrenia. Arch. Gen. Psychiatry. 55:1998;830-836
37. Traub R.D., Jefferys J.G., Whittington M.A. Fast Oscillations in Cortical Circuits. 1999;The MIT Press, Cambridge, MA
38. Turetsky B.I., Cannon T.D., Gur R.E. P300 subcomponent abnormalities in schizophrenia: III. Deficits in unaffected siblings of schizophrenic probands. Biol. Psychiatry. 47:2000;380-390
39. Umbricht D., Javitt D., Novak G., Bates J., Pollack S., Lieberman J., Kane J. Effects of clozapine on auditory event-related potentials in schizophrenia. Biol. Psychiatry. 44:1998;716-725
40. Waldo M.C., Carey G., Myles-Worsley M., Cawthra E., Adler L.E., Nagamoto H.T., Wender P., Byerley W., Plaetke R., Freedman R. Codistribution of a sensory gating deficit and schizophrenia in multi-affected families. Psychiatry Res. 39:1991;257-268
41. Whittington M.A., Traub R.D., Jefferys J.G. Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation. Nature. 373:1995;612-615
42. Yamamoto B.K., Pehek E.A., Meltzer H.Y. Brain region effects of clozapine on amino acid and monoamine transmission. J. Clin. Psychiatry. 55(Suppl. B):1994;8-14